Drugs / Mydriacyl Ophthalmic Product
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT05566626 Background | Oct 2022 → Nov 2023 | glaucoma, macular degeneration, retinal detachment | Mantis Photonics AB | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Mydriacyl Ophthalmic Product | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05566626 ↗ |